Skip to main content

Month: February 2021

Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer

AUSTIN, Texas, Feb. 11, 2021 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM; “Molecular Templates” or “MTEM”) today announced that it has entered into a worldwide strategic research collaboration with Bristol Myers Squibb to discover and develop multiple novel therapies designed for specific oncology targets. The collaboration will seek to discover new molecules utilizing MTEM’s next generation engineered toxin body (ETB) platform. ETBs represent a new class of targeted therapeutics that act through differentiated mechanisms of actions including the ability to force receptor internalization, deliver therapeutic payloads, and directly kill targeted cells through the enzymatic inactivation of ribosomes.“Bristol Myers Squibb is a leading global pharmaceutical company with a strong oncology franchise and a history of innovation,...

Continue reading

Biogen and LabCentral Award Two Golden Tickets to Local and Innovative Science Startups

Golden Tickets winners Bolden Therapeutics and Seranova Bio will have access to a state-of-the-art lab facilities at LabCentral with mentorship and support from BiogenCAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and LabCentral today announced Bolden Therapeutics and Seranova Bio as the recipients of Biogen’s Golden Tickets, an initiative offering promising winning startups one year of lab space accompanied by continued mentorship from Biogen.LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. As a platinum-level sponsor of the program, Biogen demonstrates its ongoing commitment to innovation and support for the local biotech community by awarding Golden Tickets to two companies each year. This includes up to one...

Continue reading

Plus Therapeutics to Participate in BIO CEO & Investor Digital Conference

AUSTIN, Texas, Feb. 11, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing novel, targeted and personalized therapies for rare and difficult to treat cancers, today announced that Marc Hedrick, M.D., President and Chief Executive Officer of Plus Therapeutics, will participate in the BIO CEO & Investor Digital Conference being held February 16-18, 2021.The Company’s presentation will be made through the BIO CEO & Investor Digital Conference website and available on demand to registered participants during the conference at https://www.bio.org/events/bio-ceo-investor-digital-conference/company-presentations. Subsequent to the conference, the presentation will be made available under the ‘Events’ tab of the Investor Relations section of the Plus...

Continue reading

Platinex Announces Appointment of New Director

TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (Frankfurt 9PX) (the “Company” or “Platinex“) is pleased to announce the appointment of Christophe Vereecke as a director. Mr. Vereecke is a nominee of Treasury Metals Inc. (“Treasury”) as a result of the recent sale of mining claims that are located adjacent to the Company’s Shining Tree property, and royalties whereby Treasury became an equity holder of 12.5 million shares and 5 million warrants. The acquisition by Platinex has created the largest combined gold focused property package in the Shining Tree District, Northern Ontario. The Shining Tree property is located on 21km of the Ridout-Tyrrell Deformation Zone which also hosts both IAMGOLD’s Côté Gold gold deposit and Aris Gold’s (formerly Caldas Gold) Juby deposit.Mr. Vereecke...

Continue reading

Report 2021 – DNA Sequencing Market Size, Share, Growth, Revenue, Trends, Competitive Landscape, Forecast Report

Pune, India, Feb. 11, 2021 (GLOBE NEWSWIRE) — According to the report, DNA Sequencing market size is projected to reach remarkable value by 2026. The rising advancements in DNA sequencing technologies is expected to enable growth of the global DNA sequencing market. The rising prevalence of various cancers and genetic diseases is expected to contribute to growth of the market.The collaboration of Nebula Genomics with Merck KGaA is predicted to aid growth of the DNA sequencing market. For instance, Nebula Genomics announced its collaboration Merck KGaA with the goal to enhance drug discovery for lung cancer patients and offering a free high-coverage germ line and tumor whole-genome sequencing.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dna-sequencing-market-101527Increasing...

Continue reading

IoT in Manufacturing Market Will Benefit from the Huge Potential Held by IoT in Manufacturing Equipment

Pune, india, Feb. 11, 2021 (GLOBE NEWSWIRE) — The global IoT in manufacturing market size is projected to reach USD 136.83 billion by 2026. According to a report published by Fortune Business Insights™, titled “Internet of Things (IoT) in Manufacturing Market Size, Share & Industry Analysis, By Platform (Device Management, Application Management, Network Management), By Software & Services (Software Solution and Services), By Application (Predictive Maintenance, Asset Tracking and Management, Logistics and Supply Chain Management, Real-Time Workforce Tracking and Management, Emergency and Incident Management and Others) and Regional Forecast, 2019-2026,” the market size was USD 27.76 Billion in 2018. Driven by the growing popularity and widespread applications of IoT in manufacturing industry, the market will rise at a...

Continue reading

Automotive Battery Market to reach a valuation of USD 75 billion by 2025, registering a 5.5% CAGR | Market Research Future (MRFR)

Pune, Feb. 11, 2021 (GLOBE NEWSWIRE) — Rising Automotive Production Drive the Market GrowthThe automotive battery market is growing continuously, mainly due to the growing production and sales of vehicles over the past few years. Besides, the spurring rise in the electric vehicle (EV) demand would foment innovation races around range and power. Advances in thermal management and the relative efficacy of competing battery management systems would be priorities.Auto manufacturers are focusing on improving their battery management technologies that have already altered the market capitalization. The growing demand for electric vehicles and lithium-ion & hybrid batteries would provide excellent automotive battery market opportunities. Besides, the rapid expansion in automotive industries in emerging economies such as China, India,...

Continue reading

Virtu Announces Fourth Quarter and Full Year 2020 Results

NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (NASDAQ: VIRT), a leading provider of financial services and products that leverages cutting edge technology to deliver innovative, transparent trading solutions to its clients and liquidity to the global markets, today reported results for the fourth quarter ended and full year ended December 31, 2020.Fourth Quarter 2020:Net income of $197.7 million; Normalized Adjusted Net Income¹ of $234.0 millionBasic earnings per share of $0.89 and diluted earnings per share of $0.88; Normalized Adjusted EPS¹ of $1.18Total revenues of $676.7 million; Trading income, net, of $505.5 million; Adjusted Net Trading Income¹ of $455.9 millionAdjusted EBITDA¹ of $343.9 million; Adjusted EBITDA Margin¹ of 75.4%Additional $70 million share repurchase authorized, bringing total to $170 million...

Continue reading

Cowen Announces Record Financial Results for Full Year 2020

Reports Record 4Q20 US GAAP Net Income of $90.5 million, or $2.98 per diluted shareEconomic Operating Income in 4Q20 of $138.7 million, or $4.58 per diluted share (Non-GAAP)Record FY20 US GAAP Net Income attributable to Cowen Inc. stockholders of $209.6 million and record FY20 Economic Operating income of $335.9 million (Non-GAAP)Record quarter and year for Investment Banking and BrokerageMaintained quarterly cash dividend of $0.08 per common shareNEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ: COWN) (“Cowen” or “the Company”) today announced its operating results for the fourth quarter and full year ended December 31, 2020.Jeffrey M. Solomon, Chair and Chief Executive Officer of Cowen, said, “I am proud of the dedication and hard work the Cowen team exhibited to achieve the strongest results in the firm’s...

Continue reading

Global Smart Home Market to Gain from Rising Demand for Innovative Security & Monitoring Solutions

Pune, India, Feb. 11, 2021 (GLOBE NEWSWIRE) — The global smart home market size is projected to reach USD 622.59 billion by 2026, thereby exhibiting a CAGR of 29.3% during the forecast period. Fortune Business Insights™ published this information in a recent study, titled, “Smart Home Market Size, Share & Industry Analysis, By Product (Home Monitoring/Security, Smart Lighting, Entertainment, Smart Appliances, and Others (Thermostat, etc.)), and Regional Forecast, 2019-2026.” The report further mentions that the market was valued at USD 79.90 billion in 2018. It is likely to gain momentum from the rising mergers and acquisitions between prominent companies for developing novel solutions for residences.Highlights of the ReportExtensive analysis of the competitive landscape, such as mergers, acquisitions, contracts, agreements,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.